Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Legend Biotech Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 160 | 194 | +34 |
| Shares | 68.0M | 84.3M | +16.3M (+23.9%) |
| Value | $3.28B | $5.81B | +$2.53B (+77.2%) |
New holders (49)
Institutions that held Legend Biotech Corp at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (15)
Institutions that held Legend Biotech Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Iron Triangle Partners LP | 500,000 | $24.1M |
| Vivo Capital, LLC | 244,375 | $11.8M |
| Parkman Healthcare Partners LLC | 47,608 | $2.30M |
| Moore Capital Management, LP | 25,000 | $1.21M |
| Renaissance Capital LLC | 18,300 | $882.4K |
| Farallon Capital Management, L.L.C. | 17,600 | $848.7K |
| Vident Investment Advisory, LLC | 16,260 | $784.1K |
| Indus Capital Partners, LLC | 10,064 | $485.3K |
| Capital Investment Advisory Services, LLC | 8,525 | $411.1K |
| Schonfeld Strategic Advisors LLC | 7,200 | $347.2K |
| Nomura Holdings Inc | 6,955 | $335.4K |
| Artia Global Partners LP | 5,000 | $241.1K |
| Twin Tree Management, LP | 344 | $16.6K |
| Ronald Blue Trust, Inc. | 193 | $10.0K |
| Caisse de Depot Et Placement du Quebec | 175 | $8.44K |